95 related articles for article (PubMed ID: 11397470)
21. Simvastatin and lovastatin inhibit breast cell invasion induced by H-Ras.
Kang S; Kim ES; Moon A
Oncol Rep; 2009 May; 21(5):1317-22. PubMed ID: 19360310
[TBL] [Abstract][Full Text] [Related]
22. Ciglitazone, an agonist of peroxisome proliferator-activated receptor gamma, exerts potentiated cytostatic/cytotoxic effects against tumor cells when combined with lovastatin.
Mrówka P; Glodkowska E; Nowis D; Legat M; Issat T; Makowski M; Szokalska A; Janowska S; Stoklosa T; Jakóbisiak M; Golab J
Int J Oncol; 2008 Jan; 32(1):249-55. PubMed ID: 18097565
[TBL] [Abstract][Full Text] [Related]
23. [Cytosine arabinoside as a polyvalent drug in the treatment of acute non-lymphoid leukemias].
Sánchez Fayos J
Sangre (Barc); 1986; 31(5):566-73. PubMed ID: 3810411
[No Abstract] [Full Text] [Related]
24. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
[TBL] [Abstract][Full Text] [Related]
25. Lovastatin induces apoptosis in malignant mesothelioma cells.
Rubins JB; Greatens T; Kratzke RA; Tan AT; Polunovsky VA; Bitterman P
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1616-22. PubMed ID: 9603146
[TBL] [Abstract][Full Text] [Related]
26. Synergistic interaction between highly specific cyclooxygenase-2 inhibitor, MF-tricyclic and lovastatin in murine colorectal cancer cell lines.
Feleszko W; Jalili A; Olszewska D; Mlynarczuk I; Grzela T; Giermasz A; Jakóbisiak M
Oncol Rep; 2002; 9(4):879-85. PubMed ID: 12066226
[TBL] [Abstract][Full Text] [Related]
27. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
28. Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation.
Wang IK; Lin-Shiau SY; Lin JK
Oncology; 2000 Sep; 59(3):245-54. PubMed ID: 11053993
[TBL] [Abstract][Full Text] [Related]
29. Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells.
Rombouts K; Kisanga E; Hellemans K; Wielant A; Schuppan D; Geerts A
J Hepatol; 2003 May; 38(5):564-72. PubMed ID: 12713866
[TBL] [Abstract][Full Text] [Related]
30. Lovastatin blocks basic fibroblast growth factor-induced mitogen-activated protein kinase signaling in coronary smooth muscle cells via phosphatase inhibition.
Skaletz-Rorowski A; Müller JG; Kroke A; Waltenberger J; Pulawski E; Pinkernell K; Breithardt G
Eur J Cell Biol; 2001 Mar; 80(3):207-12. PubMed ID: 11322384
[TBL] [Abstract][Full Text] [Related]
31. Statins inhibit ABCB1 and ABCG2 drug transporter activity in chronic myeloid leukemia cells and potentiate antileukemic effects of imatinib.
Glodkowska-Mrowka E; Mrowka P; Basak GW; Niesiobedzka-Krezel J; Seferynska I; Wlodarski PK; Jakobisiak M; Stoklosa T
Exp Hematol; 2014 Jun; 42(6):439-47. PubMed ID: 24667683
[TBL] [Abstract][Full Text] [Related]
32. Modulation of human T cells signaling transduction by lovastatin.
Cheng SM; Lai JH; Yang SP; Tsao TP; Ho LJ; Liou JT; Cheng CC
Int J Cardiol; 2010 Apr; 140(1):24-33. PubMed ID: 19046782
[TBL] [Abstract][Full Text] [Related]
33. Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo.
Yang SH; Lin HY; Chang VH; Chen CC; Liu YR; Wang J; Zhang K; Jiang X; Yen Y
Oncotarget; 2015 Sep; 6(27):23857-73. PubMed ID: 26160843
[TBL] [Abstract][Full Text] [Related]
34. Lovastatin and mevastatin reduce basal and cytokine-stimulated production of prostaglandins from rat microglial cells in vitro: evidence for a mechanism unrelated to the inhibition of hydroxy-methyl-glutaryl CoA reductase.
Tringali G; Vairano M; Dello Russo C; Preziosi P; Navarra P
Neurosci Lett; 2004 Jan; 354(2):107-10. PubMed ID: 14698450
[TBL] [Abstract][Full Text] [Related]
35. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.
Ramilo-Torno LV; Avramis VI
Cancer Chemother Pharmacol; 1995; 35(3):191-9. PubMed ID: 7805176
[TBL] [Abstract][Full Text] [Related]
36. Gamma-tocopherol enhances apoptotic effects of lovastatin in human colorectal carcinoma cell line (HT29).
Rezaei M; Zeidooni L; Hashemitabar M; Razzazzadeh S; Mahdavinia M; Ghasemi K
Nutr Cancer; 2014; 66(8):1386-93. PubMed ID: 25296535
[TBL] [Abstract][Full Text] [Related]
37. Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells.
Bassa BV; Roh DD; Vaziri ND; Kirschenbaum MA; Kamanna VS
Biochim Biophys Acta; 1999 Mar; 1449(2):137-49. PubMed ID: 10082972
[TBL] [Abstract][Full Text] [Related]
38. Lovastatin alters the isoprenoid biosynthetic pathway in acute myelogenous leukemia cells in vivo.
Lewis KA; Holstein SA; Hohl RJ
Leuk Res; 2005 May; 29(5):527-33. PubMed ID: 15755505
[TBL] [Abstract][Full Text] [Related]
39. Targeting PIM kinase activity significantly augments the efficacy of cytarabine.
Kelly KR; Espitia CM; Taverna P; Choy G; Padmanabhan S; Nawrocki ST; Giles FJ; Carew JS
Br J Haematol; 2012 Jan; 156(1):129-32. PubMed ID: 21689092
[No Abstract] [Full Text] [Related]
40. Ubiquinone does not rescue acute myeloid leukemia cells from growth inhibition by statins.
Burke LP; Lewis LD; Perez RP
Leukemia; 2003 Jan; 17(1):267-8. PubMed ID: 12529692
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
